Astrolabe Analytica's Message Mapping System Developed to Help Bring the Cost of Clinical Trials and R&D Under Control.Business Editors, Health & Medical Writers PHILADELPHIA--(BUSINESS WIRE)--Feb. 17, 2003 With approximately $275 million, or 35 percent, of the approximate $800 million it costs to bring a new drug from concept to the marketplace being spent on clinical trials and research and development, pharmaceutical executives are looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. ways to better control these costs. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Lawrence Lawrence. 1 City (1990 pop. 26,763), Marion co., central Ind., a residential suburb of Indianapolis, on the West Fork of the White River. It has light manufacturing. 2 City (1990 pop. 65,608), seat of Douglas co., NE Kans. Liberti LIBERTI, LIBERTINI. These two words were, at different times, made to express among the Romans, the condition of those who, having been slaves, had been made free. 1 Brown's Civ. Law, 99. There is some distinction between these words. , executive vice president of Astrolabe astrolabe (ăs`trəlāb), instrument probably used originally for measuring the altitudes of heavenly bodies and for determining their positions and movements. Analytica Analytica ® is a visual software package developed by Lumina Decision Systems, Inc. for creating, analyzing and communicating quantitative decision models. Analytica includes hierarchical influence diagrams for visual creation and view of models, intelligent arrays for management , Inc., "One of the biggest problems with controlling cost is the recruitment of specialists and patients to include in clinical trials. Often done on a hit or miss basis, millions of dollars are spent just in planning and identifying research panels and investigators for therapeutic programs." Astrolabe Analytica, Inc. has developed its ASTROLABE Message Mapping System(TM) to help pharmaceutical companies reign in these costs. "Pharmaceutical companies are using our Message Mapping System to speed up the enrollment process by using it to quickly find and identify experienced investigators who already understand a specific therapeutic area," says Liberti. "As a starting point Noun 1. starting point - earliest limiting point terminus a quo commencement, get-go, offset, outset, showtime, starting time, beginning, start, kickoff, first - the time at which something is supposed to begin; "they got an early start"; "she knew from the , Message Mapping provides an independent assessment of who has done research in a specific area, and the quality of research already published by an investigator. Later in the process of evaluating a new drug, Message Mapping points out those areas that need further R&D and exploration." The ASTROLABE Message Mapping System can also provide a competitive analysis of what has already been published. "This helps sponsors design their own studies to effectively add to a body of knowledge," comments Liberti. The ASTROLABE Message Mapping System can be used to analyze research by geographical area, and can be used to look at specific safety and efficacy parameters that are necessary in order to effectively evaluate a new drug. Astrolabe Analytica, Inc. was launched early last year as an offshoot of Pharmaceutical Information Associates, Ltd. (PIA pi·a n. The pia mater. pi  al adj. ) of Fairless Hills, PA. Its ASTROLABE Message Mapping System consists of proprietary databases and software that are accessible via a secure web site. Further information about the company and its ASTROLABE Message Mapping System can be obtained by writing to: Astrolabe Analytica, Inc., 3701 Market Street, Suite 340, Philadelphia, PA 19104, calling 215-966-6222 or visiting us on the worldwide web at www.AstrolabeAnalytica.com.
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion